Search research articles
Contact Us
Filters
Showing results (31-40 of 107) with videos related to
Page
of 11
Sort By:
Future Oncology (London, England)
|
February 14, 2024
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia
Peter J Goebell, Rutika Raina, Stephanie Chen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
May 19, 2017
CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer
Qi Pan, Anuja Sathe, Peter C Black, et al.
International Journal of Cancer
|
September 10, 2019
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry
Michael Staehler, Peter J Goebell, Lothar Müller, et al.
Aktuelle Urologie
|
June 4, 2025
[Androgen receptor-targeted therapies - avoid clinically relevant interactions]
Hans-Peter Lipp, Gunhild von Amsberg, Axel S Merseburger, et al.
Urology
|
January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
Willem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
Urologic Oncology
|
August 23, 2018
Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry
Peter J Goebell, Lothar Müller, Andreas Hübner, et al.
Journal of Clinical Medicine
|
May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Andreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Urologie (Heidelberg, Germany)
|
August 20, 2025
[Update guideline on prostate cancer-balancing act between evidence and healthcare reality]
Axel Belusa, Peter J Goebell, Peter Kollenbach, et al.
Oncology Research and Treatment
|
January 19, 2022
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)
Viktor Grünwald, Thomas Hilser, Johannes Meiler, et al.
Anticancer Research
|
October 25, 2017
Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational Study
Hendrik Heers, Patrick DE Geeter, Peter J Goebell, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 107) with videos related to
Sort By:
Page
of 11
Future Oncology (London, England)
|
February 14, 2024
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia
Peter J Goebell, Rutika Raina, Stephanie Chen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
May 19, 2017
CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer
Qi Pan, Anuja Sathe, Peter C Black, et al.
International Journal of Cancer
|
September 10, 2019
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry
Michael Staehler, Peter J Goebell, Lothar Müller, et al.
Aktuelle Urologie
|
June 4, 2025
[Androgen receptor-targeted therapies - avoid clinically relevant interactions]
Hans-Peter Lipp, Gunhild von Amsberg, Axel S Merseburger, et al.
Urology
|
January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
Willem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
Urologic Oncology
|
August 23, 2018
Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry
Peter J Goebell, Lothar Müller, Andreas Hübner, et al.
Journal of Clinical Medicine
|
May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Andreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
Urologie (Heidelberg, Germany)
|
August 20, 2025
[Update guideline on prostate cancer-balancing act between evidence and healthcare reality]
Axel Belusa, Peter J Goebell, Peter Kollenbach, et al.
Oncology Research and Treatment
|
January 19, 2022
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)
Viktor Grünwald, Thomas Hilser, Johannes Meiler, et al.
Anticancer Research
|
October 25, 2017
Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational Study
Hendrik Heers, Patrick DE Geeter, Peter J Goebell, et al.
Page
of 11